Chapter 1. Digital Therapeutics for Respiratory Diseases Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Digital Therapeutics for Respiratory Diseases Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
             2.3.1. Impact during 2023 - 2030
               2.3.2. Impact on Supply – Demand
Chapter 3. Digital Therapeutics for Respiratory Diseases Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. Digital Therapeutics for Respiratory Diseases Market - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
       4.4.1. Bargaining Power of Suppliers
       4.4.2. Bargaining Powers of Customers
       4.4.3. Threat of New Entrants
       4.4.4. Rivalry among Existing Players
       4.4.5. Threat of Substitutes
Chapter 5. Digital Therapeutics for Respiratory Diseases Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities 
Chapter 6. Digital Therapeutics for Respiratory Diseases Market - By Type
6.1    Devices
         6.1.1    Handheld Devices
       6.1.2    Portable Devices
       6.1.3    Wearable Devices
6.2    Software and Services
Chapter 7. Digital Therapeutics for Respiratory Diseases Market - By Disease Type
7.1    Asthma
7.2    Chronic Obstructive Pulmonary Disease (COPD)
7.3    Pulmonary Fibrosis
7.4    Pneumonia
7.5    Lung Cancer
7.6    Others

Chapter 8. Digital Therapeutics for Respiratory Diseases Market - By Region
8.1    North America
8.2    Europe
8.3    Asia-Pacific
8.4    Rest of the World
Chapter 9.  Digital Therapeutics for Respiratory Diseases Market - Key Players 
9.1    ResMed Inc. (United States)
9.2    KAMU Health Ltd. (Finland)
9.3    AptarGroup, Inc. (United States)
9.4    NuvoAir US, Inc. (United States)
9.5    VisionHealth (Germany)
9.6    Life Semantics Corp. (South Korea)
9.7    my mHealth Limited (United Kingdom)
9.8    Kaia Health (United States)
9.9    Respiree Pte Ltd. (Singapore)
9.10    HealthSnap, Inc. (United States)